VII. Are lymphomas driven by epigenetic lesions? (Q38523987)

3 September 2017

1 reference

title

VII. Are lymphomas driven by epigenetic lesions? (English)

1 reference

3 September 2017

Isaac W Boss

1 reference

3 September 2017

Ari M Melnick

series ordinal

1 reference

3 September 2017

publication date

1 June 2015

1 reference

3 September 2017

published in

Hematological Oncology

1 reference

3 September 2017

volume

33 Suppl 1

1 reference

3 September 2017

page(s)

42-45

1 reference

Translating the Histone Code

3 September 2017

cites work

1 reference

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

21 January 2018

1 reference

Inactivating mutations of acetyltransferase genes in B-cell lymphoma

21 January 2018

1 reference

BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy

21 January 2018

1 reference

Genetics of follicular lymphoma transformation

21 January 2018

1 reference

Control of developmental regulators by Polycomb in human embryonic stem cells

21 January 2018

1 reference

EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation

21 January 2018

1 reference

Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas

21 January 2018

1 reference

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

21 January 2018

1 reference

A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters

21 January 2018

1 reference

Histone acetyltransferase-deficient p300 mutants in diffuse large B cell lymphoma have altered transcriptional regulatory activities and are required for optimal cell growth

21 January 2018

1 reference

Analysis of the coding genome of diffuse large B-cell lymphoma

21 January 2018

1 reference

UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells

21 January 2018

1 reference

DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier

21 January 2018

1 reference

The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers

21 January 2018

1 reference

H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation

21 January 2018

1 reference

Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription.

21 January 2018

1 reference

Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages.

21 January 2018

1 reference

Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndrome

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/HON.2215

1 reference

3 September 2017

1 reference